N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by systemic microvascular thrombosis caused by adhesion of platelets to ultra-large vWF (ULVWF) multimers. These multimers accumulate because of a deficiency of the processing enzyme ADAMTS13. vWF protein forms long multimers from homodimers that first form through C-terminal disulfide bonds and then join through their N termini by further disulfide bonding. N-acetylcysteine (NAC) is an FDA-approved drug that has long been used to treat chronic obstructive lung disease and acetaminophen toxicity and is known to function in the former disorder by reducing mucin multimers. Here, we examined whether NAC could reduce vWF multimers, which polymerize in a manner similar to mucins. In vitro, NAC reduced soluble plasma-type vWF multimers in a concentration-dependent manner and rapidly degraded ULVWF multimer strings extruded from activated ECs. The effect was preceded by reduction of the intrachain disulfide bond encompassing the platelet-binding A1 domain. NAC also inhibited vWF-dependent platelet aggregation and collagen binding. Injection of NAC into ADAMTS13-deficient mice led to the rapid resolution of thrombi produced by ionophore treatment of the mesenteric venules and reduced plasma vWF multimers. These results suggest that NAC may be a rapid and effective treatment for patients with TTP.
Puget Sound Blood Center, 921 Terry Ave., Seattle, Washington 98104, USA.
Junmei
J
Chen
Adili
A
Reheman
Francisca C
FC
Gushiken
Leticia
L
Nolasco
Xiaoyun
X
Fu
Joel L
JL
Moake
Heyu
H
Ni
José A
JA
López
D000071120:ADAMTS13 Protein; D000111:Acetylcysteine / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D042783:Endothelial Cells / Q000378:metabolism; D006801:Humans; D008297:Male; D008666:Metalloendopeptidases / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010949:Plasma / Q000378:metabolism*; D010974:Platelet Aggregation / Q000187:drug effects; D055503:Protein Multimerization; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood* / Q000188:drug therapy; D012310:Ristocetin / Q000494:pharmacology; D013927:Thrombosis / Q000378:metabolism / Q000473:pathology; D014841:von Willebrand Factor / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D014841:von Willebrand Factor; D012310:Ristocetin; C502939:ADAMTS13 protein, mouse; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; D000111:Acetylcysteine
Annu Rev Biochem. 1998;67:395-424
9759493
Blood. 1996 May 15;87(10):4235-44
8639782
J Thromb Haemost. 2004 Apr;2(4):660-9
15102023
J Thromb Haemost. 2005 May;3(5):875-83
15733060
Scand J Clin Lab Invest. 1994 Nov;54(7):543-7
7863231
J Thromb Haemost. 2008 Jul;6(7):1135-43
18433456
Annu Rev Med. 2006;57:419-36
16409158
Semin Oncol. 1983 Mar;10(1 Suppl 1):76-85
6340205
J Clin Invest. 1983 Apr;71(4):980-91
6833497
Blood. 1993 May 1;81(9):2429-38
8481522
Thromb Haemost. 2000 Jan;83(1):127-35
10669166
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11069-74
16835302
Blood. 1979 Feb;53(2):333-8
570069
Blood. 2010 Feb 18;115(7):1317-8
20167709
Circulation. 2008 Mar 18;117(11):1449-59
18347221
Blood. 2005 Dec 15;106(13):4199-209
16131569
Semin Oncol. 1983 Mar;10(1 Suppl 1):17-24
6682250
N Engl J Med. 1982 Dec 2;307(23):1432-5
6813740
Blood. 2003 Jul 1;102(1):60-8
12637323
J Biol Chem. 1993 Oct 5;268(28):21238-45
8407961
Blood. 2003 May 15;101(10):3908-14
12560222
Am J Clin Pathol. 2006 Apr;125(4):592-7
16627268
J Clin Invest. 1985 Aug;76(2):703-8
2863286
J Clin Invest. 2007 Sep;117(9):2592-601
17786245
Altern Med Rev. 1998 Apr;3(2):114-27
9577247
Circulation. 2003 Jul 1;107(25):3141-5
12796127
J Clin Invest. 1986 Dec;78(6):1456-61
3491092
Eur J Clin Invest. 2001 May;31(5):452-61
11380598
J Clin Invest. 1987 Sep;80(3):905-10
3497953
Am Rev Respir Dis. 1964 Nov;90:721-9
14211458
J Pharmacol Exp Ther. 1973 Oct;187(1):211-7
4746329
Crit Care Med. 2009 Jun;37(6):1929-34
19384218
Best Pract Res Clin Haematol. 2001 Jun;14(2):437-54
11686108
Blood. 2002 Dec 1;100(12):4033-9
12393397
Pharmacology. 1974;12(4-5):251-71
4449889
Ann Biomed Eng. 2002;30(9):1107-16
12502222
Gut. 2005 Apr;54(4):515-21
15753537
J Pharmacol Exp Ther. 1973 Oct;187(1):195-202
4746327
Blood. 1994 Jun 15;83(12):3536-44
8204880
J Pharmacol Exp Ther. 1986 Jul;238(1):54-61
3723405
Blood. 2010 Feb 18;115(7):1472-4
19897581
J Clin Invest. 2000 Aug;106(3):385-92
10930441
N Engl J Med. 2008 Jul 17;359(3):285-92
18635433
Blood. 2009 Feb 19;113(8):1809-17
19036705
J Biol Chem. 1999 Nov 5;274(45):31751-4
10542193
Blood. 1996 May 15;87(10):4223-34
8639781
Pharmacology. 1974;12(3):129-43
4445191